147 related articles for article (PubMed ID: 33321289)
21. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
[TBL] [Abstract][Full Text] [Related]
22. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of a GPCR by β-Arrestin2-Mediated Switch from an Endosomal to a TGN Recycling Pathway.
Abdullah N; Beg M; Soares D; Dittman JS; McGraw TE
Cell Rep; 2016 Dec; 17(11):2966-2978. PubMed ID: 27974210
[TBL] [Abstract][Full Text] [Related]
24. Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced.
Fujii H; Tamamori-Adachi M; Uchida K; Susa T; Nakakura T; Hagiwara H; Iizuka M; Okinaga H; Tanaka Y; Okazaki T
PLoS One; 2014; 9(10):e110543. PubMed ID: 25334044
[TBL] [Abstract][Full Text] [Related]
25. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Verma MK; Goel R; Krishnadas N; Nemmani KVS
Expert Opin Ther Targets; 2018 Jul; 22(7):615-628. PubMed ID: 29911915
[TBL] [Abstract][Full Text] [Related]
26. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
28. Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptor.
Smit FX; van der Velden WJC; Kizilkaya HS; Nørskov A; Lückmann M; Hansen TN; Sparre-Ulrich AH; Qvotrup K; Frimurer TM; Rosenkilde MM
Structure; 2021 Jul; 29(7):679-693.e6. PubMed ID: 33891864
[TBL] [Abstract][Full Text] [Related]
29. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes.
Nie Y; Ma RC; Chan JC; Xu H; Xu G
FASEB J; 2012 Jun; 26(6):2383-93. PubMed ID: 22366643
[TBL] [Abstract][Full Text] [Related]
30. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
31. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
[TBL] [Abstract][Full Text] [Related]
32. GIP attenuates neuronal oxidative stress by regulating glucose uptake in spinal cord injury of rat.
Guo B; Qi M; Luo X; Guo L; Xu M; Zhang Y; Li Z; Li M; Wu R; Guan T; Liu M; Liu Y
CNS Neurosci Ther; 2024 Jun; 30(6):e14806. PubMed ID: 38887182
[TBL] [Abstract][Full Text] [Related]
33. Human GIP(3-30)NH
Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
[TBL] [Abstract][Full Text] [Related]
34. Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor.
Yuliantie E; van der Velden WJC; Labroska V; Dai A; Zhao F; Darbalaei S; Deganutti G; Xu T; Zhou Q; Yang D; Rosenkilde MM; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2021 Oct; 192():114715. PubMed ID: 34339714
[TBL] [Abstract][Full Text] [Related]
35. Molecular evolution of GIP and Exendin and their receptors.
Irwin DM
Peptides; 2020 Mar; 125():170158. PubMed ID: 31582191
[TBL] [Abstract][Full Text] [Related]
36. The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system.
Adriaenssens AE; Gribble FM; Reimann F
Peptides; 2020 Mar; 125():170194. PubMed ID: 31697967
[TBL] [Abstract][Full Text] [Related]
37. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
[TBL] [Abstract][Full Text] [Related]
38. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome.
Antonini SR; Baldacchino V; Tremblay J; Hamet P; Lacroix A
Clin Endocrinol (Oxf); 2006 Jan; 64(1):29-36. PubMed ID: 16402925
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding.
Adriaenssens A; Broichhagen J; de Bray A; Ast J; Hasib A; Jones B; Tomas A; Burgos NF; Woodward O; Lewis J; O'Flaherty E; El K; Cui C; Harada N; Inagaki N; Campbell J; Brierley D; Hodson DJ; Samms R; Gribble F; Reimann F
JCI Insight; 2023 May; 8(10):. PubMed ID: 37212283
[TBL] [Abstract][Full Text] [Related]
40. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
Al-Sabah S; Al-Fulaij M; Shaaban G; Ahmed HA; Mann RJ; Donnelly D; Bünemann M; Krasel C
PLoS One; 2014; 9(9):e106890. PubMed ID: 25191754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
